Abstract
Background and aims
Crohn's disease is strongly associated with double mutations in NOD2/CARD15. Three common mutations (Arg702Trp, Gly908Arg, Leu1007fs) impair innate immune responses to bacterial muramyl dipeptide. Rare NOD2 variants occur, but it is difficult to both identify them and assess their functional effect. We assessed the true frequency of defective muramyl dipeptide sensing in Crohn's disease and developed a rapid diagnostic assay.Materials and methods
An ex vivo assay was established and validated based on muramyl dipeptide stimulation of peripheral blood mononuclear cell cytokine production. Muramyl dipeptide-induced enhancement of interleukin (IL)-8 secretion and synergistic increase in lipopolysaccharide-induced IL-1beta secretion were studied. Assay results were compared with NOD2 genotype status (3 common mutations and rare variants) in 91 individuals including a prospective cohort of 49 patients with Crohn's disease.Results
The assay was highly sensitive and specific for detection of profound defects in muramyl dipeptide sensing caused by double NOD2 mutations (IL-8 P = 0.0002; IL-1beta P = 0.0002). Disease state, active inflammation, or concurrent use of immunosuppressive medication did not influence results. Healthy NOD2 heterozygotes had modest impairment of muramyl dipeptide induced IL-8 secretion (P = 0.003). Only 1 of 7 patients with Crohn's disease with both a common mutation and a rare variant had a profound muramyl dipeptide-sensing defect.Conclusions
Profound defects in muramyl dipeptide sensing were found in 10% of patients with Crohn's disease. Defects were caused exclusively by inherited mutations in NOD2. The ex vivo assay has multiple potential applications as a clinical diagnostic tool to distinguish patients with muramyl dipeptide-sensing defects and for research investigation.Full text links
Read article at publisher's site: https://doi.org/10.1097/01.ibd.0000225344.21979.89
References
Articles referenced by this article (25)
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.
Nature, (6837):599-603 2001
MED: 11385576
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.
Nature, (6837):603-606 2001
MED: 11385577
Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis.
Am J Gastroenterol, (12):2393-2404 2004
MED: 15571588
CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease.
Am J Hum Genet, (4):845-857 2002
MED: 11875755
Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease.
Lancet, (9473):1794-1796 2005
MED: 15910952
Mutation, selection, and evolution of the Crohn disease susceptibility gene CARD15.
Hum Mutat, (1):44-54 2006
MED: 16278823
NOD proteins: an intracellular pathogen-recognition system or signal transduction modifiers?
Curr Opin Immunol, (4):352-358 2005
MED: 15950446
Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract.
Science, (5710):731-734 2005
MED: 15692051
Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing.
Science, (5710):734-738 2005
MED: 15692052
Show 10 more references (10 of 25)
Citations & impact
Impact metrics
Citations of article over time
Article citations
Interaction Between NOD2 and Smoking in the Pathogenesis of Crohn's Disease.
EBioMedicine, 21:49-50, 19 Jun 2017
Cited by: 0 articles | PMID: 28684279 | PMCID: PMC5514429
Review Free full text in Europe PMC
Killing of Escherichia coli by Crohn's Disease Monocyte-derived Macrophages and Its Enhancement by Hydroxychloroquine and Vitamin D.
Inflamm Bowel Dis, 21(7):1499-1510, 01 Jul 2015
Cited by: 14 articles | PMID: 25839777 | PMCID: PMC4894789
Immuno-genomic profiling of patients with inflammatory bowel disease: a systematic review of genetic and functional in vivo studies of implicated genes.
Inflamm Bowel Dis, 20(10):1813-1819, 01 Oct 2014
Cited by: 6 articles | PMID: 25171511
Review
A genome-wide small interfering RNA (siRNA) screen reveals nuclear factor-κB (NF-κB)-independent regulators of NOD2-induced interleukin-8 (IL-8) secretion.
J Biol Chem, 289(41):28213-28224, 28 Aug 2014
Cited by: 29 articles | PMID: 25170077 | PMCID: PMC4192477
A case-only study of gene-environment interaction between genetic susceptibility variants in NOD2 and cigarette smoking in Crohn's disease aetiology.
BMC Med Genet, 13:14, 14 Mar 2012
Cited by: 22 articles | PMID: 22416979 | PMCID: PMC3314543
Go to all (18) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations.
Hum Mol Genet, 13(16):1715-1725, 15 Jun 2004
Cited by: 195 articles | PMID: 15198989
Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease.
Lancet, 365(9473):1794-1796, 01 May 2005
Cited by: 215 articles | PMID: 15910952
Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease.
J Biol Chem, 278(8):5509-5512, 04 Jan 2003
Cited by: 1043 articles | PMID: 12514169
Muramyl dipeptide responsive pathways in Crohn's disease: from NOD2 and beyond.
Cell Mol Life Sci, 70(18):3391-3404, 29 Dec 2012
Cited by: 19 articles | PMID: 23275943 | PMCID: PMC11113952
Review Free full text in Europe PMC
Towards an understanding of the role of NOD2/CARD15 in the pathogenesis of Crohn's disease.
Best Pract Res Clin Gastroenterol, 18(3):555-568, 01 Jun 2004
Cited by: 11 articles | PMID: 15157827
Review
Funding
Funders who supported this work.